We order diagnostic and lab testing as well as all current treatment modalities (oral bisphosphonates, abaloparatide (Tymlos), denosumab (Prolia), teraparatide (Forteo), romosozumab (Evenity).   We are able to interpret bone density studies and other risk factors to determine the course of treatment.